Copyright © 2007 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 80, Issue 5, 971-981, 1 May 2007
doi:10.1086/516843
Report
Laura Crisponi*, a, Giangiorgio Crisponi*, b,
,
, Alessandra Melonia, Mohammad Reza Toliatd, e, Gudrun Nürnbergd, g, Gianluca Usalaa, Manuela Udaa, Marco Masala, Wolfgang Höhneh, Christian Beckerd, g, Mara Marongiu, Francesca Chiappec, Robert Kletaj, Anita Rauchi, Bernd Wollnikf, Friedrich Strasserk, Thomas Reese, Cornelis Jakobsm, Gerd Kurlemannn, Antonio Caoa, Peter Nürnbergd, e and Frank Rutscho
a Istituto di Neurogenetica e Neurofarmacologia, Consiglio Nazionale delle Ricerche, Cittadella Universitaria di Monserrato
b Casa di cura Sant’Anna Cagliari, Italy
c Università degli Studi di Cagliari Cagliari, Italy
d Cologne Center for Genomics
e Institute for Genetics Charité–Universitätsmedizin Berlin
f Center for Molecular Medicine Cologne, and Institute of Human Genetics Charité–Universitätsmedizin Berlin
g University of Cologne, Cologne; RZPD Deutsches Ressourcenzentrum für Genomforschung Charité–Universitätsmedizin Berlin
h Institute of Biochemistry, Charité–Universitätsmedizin Berlin
i Berlin; Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany
j Centre for Nephrology, University College London, Royal Free Hospital, London
k Pediatric Practitioner, Nabburg, Germany (F.S.)
l Klinik für Kinder- und Jugendmedizin, Mathias-Spital, Rheine, Germany
m Department of Clinical Chemistry and Pediatrics, VU University Medical Center, Amsterdam
n and Departments of Pediatric Neurology (G.K.)
o General Pediatrics University Children’s Hospital, Münster, Germany
Address for correspondence and reprints: Dr. Laura Crisponi, Istituto di Neurogenetica e Neurofarmacologia–Consiglio Nazionale delle Ricerche c/o Cittadella Universitaria di Monserrato, Strada statale 554 bivio per Sestu km 4500, 09042 Monserrato (Cagliari), Italy.Abstract
Crisponi syndrome is a severe autosomal recessive condition that is phenotypically characterized by abnormal, paroxysmal muscular contractions resembling neonatal tetanus, large face, broad nose, anteverted nares, camptodactyly, hyperthermia, and sudden death in most cases. We performed homozygosity mapping in five Sardinian and three Turkish families with Crisponi syndrome, using high-density single-nucleotide polymorphism arrays, and identified a critical region on chromosome 19p12-13.1. The most prominent candidate gene was CRLF1, recently found to be involved in the pathogenesis of cold-induced sweating syndrome type 1 (CISS1). CISS1 belongs to a group of conditions with overlapping phenotypes, also including cold-induced sweating syndrome type 2 and Stüve-Wiedemann syndrome. All these syndromes are caused by mutations of genes of the ciliary neurotrophic factor (CNTF)–receptor pathway. Here, we describe the identification of four different CRLF1 mutations in eight different Crisponi-affected families, including a missense mutation, a single-nucleotide insertion, and a nonsense and an insertion/deletion (indel) mutation, all segregating with the disease trait in the families. Comparison of the mutation spectra of Crisponi syndrome and CISS1 suggests that neither the type nor the location of the CRLF1 mutations points to a phenotype/genotype correlation that would account for the most severe phenotype in Crisponi syndrome. Other, still-unknown molecular factors may be responsible for the variable phenotypic expression of the CRLF1 mutations. We suggest that the syndromes can comprise a family of “CNTF-receptor–related disorders,” of which Crisponi syndrome would be the newest member and allelic to CISS1.
| Mutations in Cytokine Receptor-Like Factor 1 (CRLF1) Account for Both Crisponi and Cold-Induced Sweating Syndromes The American Journal of Human Genetics, Volume 80, Issue 5, 1 May 2007, Pages 966-970 N. Dagoneau, S. Bellais, P. Blanchet, P. Sarda, L.I. Al-Gazali, M. Di Rocco, C. Huber, F. Djouadi, C. Le Goff, A. Munnich and V. Cormier-Daire Abstract Crisponi syndrome is a rare autosomal recessive disorder characterized by congenital muscular contractions of facial muscles, with trismus in response to stimuli, dysmorphic features, bilateral camptodactyly, major feeding and respiratory difficulties, and access of hyperthermia leading to death in the first months of life. The overlap with Stüve-Wiedemann syndrome (SWS) is striking, but the two conditions differ in that congenital lower limb bowing is absent in Crisponi syndrome, whereas it is a cardinal feature of SWS. We report here the exclusion of the leukemia inhibitory factor receptor gene in Crisponi syndrome and the identification of homozygote or compound heterozygote cytokine receptor-like factor 1 (CRLF1) mutations in four children from three unrelated families. The four mutations were located in the immunoglobulin-like and type III fibronectin domains, and three of them predicted premature termination of translation. Using real-time quantitative polymerase chain reaction, we found a significant decrease in CRLF1 mRNA expression in patient fibroblasts, which is suggestive of a mutation-mediated decay of the abnormal transcript. CRLF1 forms a heterodimer complex with cardiotrophin-like cytokine factor 1, and this heterodimer competes with ciliary neurotrophic factor for binding to the ciliary neurotrophic factor receptor (CNTFR) complex. The identification of CRLF1 mutations in Crisponi syndrome supports the key role of the CNTFR pathway in the function of the autonomic nervous system. Abstract | | |
| Cold-Induced Sweating Syndrome Is Caused by Mutations in the CRLF1 Gene The American Journal of Human Genetics, Volume 72, Issue 2, 1 February 2003, Pages 375-383 Per M. Knappskog, Jacek Majewski, Avi Livneh, Per Torgeir E. Nilsen, Jorunn S. Bringsli, Jürg Ott and Helge Boman Abstract In 1978, Sohar et al. described a strikingly peculiar syndrome in two Israeli sisters. These young women responded to environmental temperatures of 18°C–7°C with profuse sweating on large segments on their back and chest. Both had additional abnormalities, including a high-arched palate, nasal voice, depressed nasal bridge, inability to fully extend their elbows, and kyphoscoliosis. We have observed this disorder in two Norwegian brothers. Genomewide screening in the two families, followed by saturation marker studies and linkage analysis, identified a 1.4-Mb homozygous candidate region on chromosome 19p12. The maximum multipoint LOD score was 4.22. In both families, DNA sequencing of 25 genes within the candidate region identified potentially deleterious CRLF1 sequence variants that were not found in unaffected control individuals. Our findings confirm that the cold-induced sweating syndrome is an autosomal recessive disorder that is probably caused by impaired function of the CRLF1 gene, and they suggest important developmental functions for human CRLF1. Abstract | | |
| FOXL2 and BPES: Mutational Hotspots, Phenotypic Variability, and Revision of the Genotype-Phenotype Correlation The American Journal of Human Genetics, Volume 72, Issue 2, 1 February 2003, Pages 478-487 Elfride De Baere, Diane Beysen, Christine Oley, Birgit Lorenz, Julie Cocquet, Paul De Sutter, Koen Devriendt, Michael Dixon, Marc Fellous, Jean-Pierre Fryns, Arturo Garza, Christoffer Jonsrud, Pasi A. Koivisto, Amanda Krause, Bart P. Leroy, Françoise Meire, Astrid Plomp, Lionel Van Maldergem, Anne De Paepe, Reiner Veitia and Ludwine Messiaen Abstract Blepharophimosis syndrome (BPES), an autosomal dominant syndrome in which an eyelid malformation is associated (type I) or not (type II) with premature ovarian failure (POF), has recently been ascribed to mutations in FOXL2, a putative forkhead transcription factor gene. We previously reported 22 FOXL2 mutations and suggested a preliminary genotype-phenotype correlation. Here, we describe 21 new FOXL2 mutations (16 novel ones) through sequencing of open reading frame, 5′ untranslated region, putative core promoter, and fluorescence in situ hybridization analysis. Our study shows the existence of two mutational hotspots: 30% of FOXL2 mutations lead to polyalanine (poly-Ala) expansions, and 13% are a novel out-of-frame duplication. In addition, this is the first study to demonstrate intra- and interfamilial phenotypic variability (both BPES types caused by the same mutation). Furthermore, the present study allows a revision of the current genotype-phenotype correlation, since we found exceptions to it. We assume that for predicted proteins with a truncation before the poly-Ala tract, the risk for development of POF is high. For mutations leading to a truncated or extended protein containing an intact forkhead and poly-Ala tract, no predictions are possible, since some of these mutations lead to both types of BPES, even within the same family. Poly-Ala expansions may lead to BPES type II. For missense mutations, no correlations can be made yet. Microdeletions are associated with mental retardation. We conclude that molecular testing may be carefully used as a predictor for POF risk in a limited number of mutations. Abstract | | |